Quick Answer
Rein Therapeutics, Inc. reported Net Income of -$49.87 million for fiscal year 2025.
Rein Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$49.87M | +20.7% |
| 2024 | -$62.88M | -299.7% |
| 2023 | -$15.73M | +42.4% |
| 2022 | -$27.33M | -4.5% |
| 2021 | -$26.16M | +4.3% |
| 2020 | -$27.33M | +6.9% |
| 2019 | -$29.37M | +6.9% |
| 2018 | -$31.55M | -39.6% |
| 2017 | -$22.60M | -24.7% |
| 2016 | -$18.12M | -40.7% |
| 2015 | -$12.88M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.58M | +4.5% | +18.2% |
| June 30, 2025 | -$6.82M | +23.7% | -24.0% |
| March 31, 2025 | -$5.50M | +22.7% | +5.9% |
| September 30, 2024 | -$5.85M | -220.0% | +34.6% |
| June 30, 2024 | -$8.94M | -400.4% | -25.7% |
| March 31, 2024 | -$7.11M | -48.8% | -289.3% |
| September 30, 2023 | -$1.83M | +71.3% | -2.2% |
| June 30, 2023 | -$1.79M | +77.6% | +62.6% |
- Rein Therapeutics, Inc. showed an increase of +20.7% in Net Income compared to the prior fiscal year.
- Over the 2015–2025 period, Rein Therapeutics, Inc.’s net income has declined by 287.3% (from -$12.88 million to -$49.87 million).
- The most recent figure is from Rein Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: